What Mylab Discovery Solutions does

Mylab Discovery Solutions Limited is an India-based in-vitro diagnostics company founded in 2016 and headquartered in Lonavla, operating with a small employee base of 11-50 staff. The company develops and manufactures rapid point-of-care diagnostic test kits, with two core commercial products: a pair of rapid dengue detection tests launched in August 2023 that deliver results in 15-20 minutes without laboratory infrastructure, and the PregaScreen home pregnancy test launched on June 10, 2025 for the direct-to-consumer retail market. Its underlying technology centers on rapid lateral-flow assay platforms targeting decentralized and home-based testing use cases.

The company generates revenue primarily through hardware sales of its diagnostic test kits, distributed via two distinct channels: point-of-care channels serving healthcare providers and clinical settings (for dengue and other professional-use kits), and retail/physical storefront channels targeting individual consumers for at-home self-testing products. Pricing is not publicly disclosed, and no enterprise customer logos, contract structures, or recurring revenue streams are evidenced in available data. In June 2023, Mylab secured a strategic minority investment of ₹106 crore (approximately $12.9M USD) from Zydus Lifesciences via its subsidiary Zydus Animal Health & Investments, which acquired a 6.5% equity stake and is positioned as a distribution and research partner for decentralized healthcare solutions in India. The company also acquired Sanskritech Smart Solutions in September 2021 for an undisclosed sum, and its primary historical investor appears to be Rising Sun Holdings. Mylab operates exclusively in the Indian domestic market, with no international footprint claimed, and its core customer segments span healthcare providers, clinical settings, and consumer self-testers.

Name

Mylab Discovery Solutions

Legal name

Mylab Discovery Solutions Limited

Website

https://mylabdiscoverysolutions.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Mylab Discovery Solutions is an India-based in-vitro diagnostics company that develops rapid point-of-care test kits, including dengue detection tests and the PregaScreen home pregnancy test, serving healthcare providers, clinical settings, and retail consumers.

Ownership category

akta.pro rank

Product category

In-vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• In-vitro diagnostics
• Rapid diagnostic tests
• Point-of-care testing
• Home pregnancy tests
• Dengue detection kits

Headquarters

HQ city

Lonavla

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales

Revenue model

1. In-vitro Diagnostics Products: Mylab generates revenue through the sale of in-vitro diagnostic products including rapid test kits for dengue detection and home pregnancy tests. The company operates in the diagnostics sector providing products for both professional use and consumer self-testing.

Go-to-market motion1 record

Distribution channels2 records

Core offering

Mylab Discovery Solutions Limited is an in-vitro diagnostics manufacturer that develops and produces rapid diagnostic test kits. Its portfolio includes rapid dengue detection tests intended for healthcare/clinical use and the PregaScreen home pregnancy test intended for consumer self-testing. Both product lines are designed to deliver results in approximately 15-20 minutes without requiring laboratory infrastructure.

Product overview

Mylab Discovery Solutions is an India-based in-vitro diagnostics company that develops and manufactures rapid diagnostic tests. The company offers a portfolio of point-of-care testing products including the PregaScreen home pregnancy test and rapid dengue detection tests. The products are designed for decentralized testing, enabling users to obtain results at home or in clinical settings without laboratory infrastructure.

Differentiator

Problem solved

Functional benefit

Brands

• PregaScreen: Home pregnancy test launched by Mylab Discovery Solutions
• Rapid Dengue Detection Tests

Products and services

• PregaScreen Home Pregnancy Test An at-home rapid pregnancy test kit designed for individual consumer self-testing, delivering results in approximately 15-20 minutes without requiring laboratory infrastructure.
• Rapid Dengue Detection Test A rapid in-vitro diagnostic test kit for dengue pathogen detection, designed for healthcare providers and clinical point-of-care use, producing results in approximately 15-20 minutes without laboratory processing.

Quantifiable outcome

• Results delivered in 15-20 minutes for dengue detection tests

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Molbio Diagnostics: India-based molecular and rapid diagnostics manufacturer with a Truenat platform deployed across point-of-care settings. Direct comp to Mylab in the Indian IVD manufacturing space serving decentralized healthcare.
• J. Mitra & Co. India-based diagnostics manufacturer specializing in ELISA, rapid test kits, and blood screening reagents. Directly comparable product portfolio to Mylab's rapid IVD test kits.
• Tulip Group: Indian diagnostics company focused on rapid immunodiagnostic test kits and pregnancy tests, including branded consumer products. Directly competitive with Mylab in rapid tests and home pregnancy test categories.
• HiMedia Laboratories: India-based manufacturer of microbiology, diagnostics, and life science products, including rapid test kits. Comparable Indian IVD manufacturer with reagent and kit offerings similar to Mylab.
• Agappe Diagnostics: Indian IVD company offering reagents, rapid test kits, and instruments across clinical chemistry and immunodiagnostics. Comparable product strategy and India market focus to Mylab.

Broad incumbents

• Transasia Bio-Medicals: One of India's largest IVD players with a wide portfolio of reagents and diagnostic instruments across clinical chemistry, immunoassays, and rapid tests. Compares to Mylab as an Indian IVD manufacturer serving clinical laboratories.
• SD Biosensor: Korean IVD manufacturer with a wide portfolio of rapid diagnostic test kits (including COVID-19 antigen, dengue, pregnancy) sold globally. Comparable product mix to Mylab with strong rapid-test franchise.
• Trivitron Healthcare: India-headquartered medical technology company with broad IVD and medical device portfolio covering immunoassay, hematology, and rapid diagnostics. Comparable breadth and India presence to Mylab.
• Abbott (Diagnostics): Global IVD giant with rapid test products including Panbio dengue and pregnancy tests. Comparable core categories to Mylab, though Abbott operates globally across a much broader portfolio.

Regional players

• Bhat Bio-Tech India: India-based diagnostics manufacturer with portfolio of rapid test kits and immunoassay products. Similar manufacturing base and product overlap with Mylab within India.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mylabdiscoverysolutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mylab Discovery Solutions